Private Equity

Updated:

Parkstone Growth Partners

Parkstone Growth Partners are business building investment partners; experts in healthcare, consumer, and insurance sectors dedicated to business growth and...

Parkstone Growth Partners logo

Parkstone Growth Partners

Parkstone Growth Partners are business building investment partners; experts in healthcare, consumer, and insurance sectors dedicated to business growth and operational excellence.

General information

Firm type

Private Equity

Year founded

2017

AUM

Undisclosed

Location

Region

North America

Country

United States

City

New York

Corporate office

New York, NY, United States

Principals

Lou Marinaccio

Founder

Dylan Kindler

Partner

Sector focus

Healthcare ServicesConsumerInsurTech

Frequently asked questions

Who runs investment decisions at Parkstone Growth Partners?

Founder Lou Marinaccio is the sole decision-maker on new investments, drawing on 18 years of deal experience as a Partner at North Castle Partners. Partner Dylan Kindler, who joined in 2018, supports sourcing, due diligence and portfolio operations. The firm’s website lists no additional investment committee members.

Does Parkstone Growth Partners operate like a traditional private equity firm?

Parkstone explicitly markets itself as an alternative to traditional private equity. Its partners take hands-on operating roles inside portfolio companies — including as CEO or President — rather than installing third-party executives. Marinaccio currently serves as CEO of portfolio company Physical Therapy Billing Services, and Kindler as President.

What types of businesses does Parkstone Growth Partners target?

The firm targets entrepreneurial, founder-led businesses in healthcare, consumer and insurance sectors. Known investments span revenue cycle management, autism therapy, dental service organizations and adolescent behavioral health — all lower-middle-market service providers, primarily in Florida.

Does Parkstone Growth Partners participate in fund commitments or only direct deals?

Parkstone appears to operate exclusively through direct control investments, with no public indication of fund-of-fund commitments or LP stakes in external private equity vehicles.

Where does Parkstone Growth Partners’ capital come from?

The source of Parkstone’s investment capital is not publicly disclosed. The firm does not reference a parent family office or a disclosed LP base, and its AUM remains undisclosed.

How is Parkstone Growth Partners different from a family office?

Parkstone is a manager of external private equity assets, not a family office. Unlike a single-family office that invests a single family’s wealth, Parkstone’s capital sources are not publicly tied to a specific family, and the firm markets itself as an investment manager rather than a private wealth vehicle.

What is Parkstone Growth Partners’ known posture on co-investments?

The firm has not publicly disclosed a co-investment program or any history of syndicating equity alongside external general partners. Its known transactions appear to have been wholly controlled platform investments, including the 2018 formation of Parkview Dental Partners with Bayview Dental Partners.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on private equity firms?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

Browse by category

More New York Private Equity profiles